Vervain Safety: Pregnancy, Interactions and Iron
Vervain (Verbena officinalis) has an undramatic safety record. Most people who drink it as an occasional bitter tea will have no trouble, and there is no scandal here comparable to comfrey's alkaloids or kava's liver signal. But "undramatic" is doing two different jobs in that sentence — some of it reflects a genuinely mild herb consumed at small doses, and some of it reflects the fact that almost nothing has been measured. Those need separating, and this page separates them.
Three things do deserve attention: pregnancy, where a traditional emmenagogue reputation appears independently in two unrelated systems of medicine and points the same way; iron, where a tannin-containing infusion drunk with meals has a real and well-documented effect on non-haem iron absorption; and additive sedation, which is plausible, unstudied, and matters to anyone already taking something that makes them drowsy.
Table of Contents
- How to Read a Herbal Safety Page
- The Name Implies a Safety It Has Not Earned
- Pregnancy: A Caution Bordering on Contraindication
- Breastfeeding
- Iron: The Tannin Problem, and How to Sidestep It
- Additive Sedation
- Anticoagulants and Antiplatelets
- Other Theoretical Interactions
- Dose and Exposure: Tea Is Not a Capsule
- Allergy, Skin and the Essential-Oil Confusion
- Identity and Quality Are Safety Issues
- Who the Research Raises Concerns For
- What Is Missing
- Key Research Papers
- Connections
- Featured Videos
How to Read a Herbal Safety Page
Two phrases appear constantly in herbal safety writing and both mean roughly the opposite of what a reader assumes. Translating them is the most useful thing this page can do.
- "No known interactions" means no interaction study has been done. It is a statement about the literature, not about the herb. For vervain there is no published interaction study with any drug, so every interaction below is theoretical, and "theoretical" here means unquantified rather than unlikely.
- "No case reports" reflects the absence of surveillance. Nobody systematically collects adverse events from herbal teas. A person who becomes unusually drowsy after adding a nightly herbal infusion to a sedative prescription does not generate a publication. So an empty case-report literature is weak evidence of safety and no evidence at all of the absence of risk.
The practical consequence is an asymmetry. Where a plausible mechanism exists and the outcome would be serious, the absence of data is a reason for more caution, not less. Where the mechanism is plausible and the outcome is mild, the same absence is much less alarming. We apply that asymmetry explicitly below rather than hedging everything equally.
The Name Implies a Safety It Has Not Earned
Common names carry implications, and vervain's are unusually flattering. Herb of grace, holy herb, herba sacra, simpler's joy, enchanter's plant — every one of those reads as benign, protective, gentle. A herb associated with altars and blessings does not sound like a herb to avoid in pregnancy.
The species epithet reinforces the impression. Officinalis means "of the officina", the storeroom of a monastic pharmacy — in other words, "kept in the shop". It is a record of commercial ubiquity, not of testing, and it appears on plants ranging from the innocuous to the frankly hazardous.
Compare motherwort, whose name works in the opposite direction: "mother" historically meant the uterus and "throw-wort" referred to the throes of labour, so the name literally announces that the plant acts on the uterus — which is exactly why it is contraindicated in pregnancy. Vervain has the same pregnancy caution and none of the linguistic warning. If anything the naming makes it more likely to be taken casually. Worth knowing that the reassurance is coming from the label, not the pharmacology.
Pregnancy: A Caution Bordering on Contraindication
This is the most important section on the page. Two unrelated traditions list vervain as unsuitable in pregnancy, and a 2019 rat study found harm to the unborn young at high doses. Here is precisely what supports the caution, and how strong it is.
What supports the caution:
- Traditional emmenagogue use. Vervain appears in the European herbal record as a herb used to bring on delayed menstruation. An emmenagogue reputation is, historically, frequently a euphemism, and in any case a herb used deliberately to provoke menstrual bleeding is not one to take while pregnant.
- Traditional use to promote or ease labour. The old literature also places vervain among herbs given in childbirth. That is a claim of uterine activity from within the tradition itself.
- Independent agreement from Chinese medicine. The same species is used in China as ma bian cao, classified as a blood-moving, stasis-breaking herb, and traditionally listed as one to avoid in pregnancy. Two unrelated bodies of practice reaching the same warning about the same plant is much more persuasive than either alone, because they cannot have copied each other.
- One animal study, and no human data. One rat prenatal developmental toxicity study of V. officinalis has been published (2019), and it found harm at high doses (below). There are no human pregnancy exposure data for V. officinalis in the public literature. Nothing exists that could reduce the concern.
The 2019 rat study. Researchers in Malaysia followed the international OECD test guideline 414 for prenatal developmental toxicity. Fifty pregnant rats were split into five groups of ten: four received vervain extract by mouth once a day from day 6 to day 20 of pregnancy, at 500, 1,000, 2,000 or 3,000 mg/kg, and the fifth served as an untreated control. No mother rats died, but their weight gain was significantly reduced, particularly at 2,000 and 3,000 mg/kg. The foetuses weighed less, more embryos were lost before and after implantation, and the foetuses of mothers given 2,000 and 3,000 mg/kg showed incomplete bone formation (ossification) in the skull, breastbone (sternebrae) and foot bones (metatarsals). The authors concluded that “the use of V. officinalis during pregnancy is not safe”. Their introduction also mentions a case report in which drinking vervain was followed by a miscarriage (an abortifacient effect). These are results in rats given concentrated extract at high doses; no study in pregnant women exists.
What does not support it: there is essentially no modern pharmacology demonstrating a uterine effect for V. officinalis — no well-characterised isolated-tissue contractility work we are willing to cite, no identified uterotonic constituent, no mechanism. The caution rests on two convergent traditions plus one rat study that found harm to foetuses at high doses. No effect on the womb itself has been measured.
The same reasoning appears on the motherwort and raspberry leaf pages: the potential harm is a pregnancy loss, the benefit on offer is a marginally better night's sleep, and the only data that exist — one rat study — point towards harm rather than safety.
Two practical notes. First, incidental exposure — a cup of a herbal blend drunk before the pregnancy was known — is a very different exposure from the daily high doses of extract given to the rats. Second, and importantly, this warning is about common vervain. If your tea is lemon verbena (Aloysia citrodora), that is a different plant in a different genus, and the emmenagogue tradition does not attach to it — though it too lacks pregnancy safety data, and "no data" remains "no data". How to tell the plants apart is covered in Which Vervain?.
Breastfeeding
Here the traditional record is genuinely contradictory, which is worth reporting as the finding rather than resolving artificially.
Some sources list vervain among galactagogues — herbs held to increase milk supply — and it appears in nursing-tea traditions in parts of Europe. Others carry it forward from the pregnancy caution and advise avoidance throughout lactation. Both positions are traditional; neither is tested.
What is known: nothing. There is no study of vervain constituents in human milk, no infant exposure data, and no controlled work on milk supply. Verbenalin, hastatoside and verbascoside have not been measured in milk because they have not been measured in human plasma either.
In short, vervain carries a pregnancy caution and has no lactation data at all, and the galactagogue tradition has never been tested. Other evening herbal teas have more safety documentation in breastfeeding than vervain does.
Iron: The Tannin Problem, and How to Sidestep It
This is the interaction most likely to affect an actual reader, and it is also the best-evidenced thing on this page — vervain tea itself was one of the drinks measured in a controlled human iron-absorption study.
The mechanism. Polyphenols, including the tannins in vervain, bind non-haem iron in the gut lumen and form complexes that are not absorbed. Non-haem iron is the form in plant foods, eggs, dairy and iron supplements — that is, most dietary iron for most people, and essentially all of it for vegetarians. Haem iron from meat is far less affected.
The evidence. Controlled human absorption studies established this decades ago. Work published in Gut in the 1970s showed tea substantially reducing iron absorption from a meal. A 1999 study in the British Journal of Nutrition (Hurrell, Reddy and Cook) measured iron absorption from a bread meal in adult volunteers, using radio-labelled iron, with a panel of polyphenol-containing drinks that included vervain tea (Verbena officinalis). All the drinks were potent inhibitors of iron absorption, and the effect rose with total polyphenol content: drinks with 20–50 mg of polyphenols per serving cut iron absorption from the meal by 50–70%, and drinks with 100–400 mg by 60–90%. Vervain tea cut iron absorption by 59%. The other figures were black tea 79–94%, peppermint tea 84%, pennyroyal 73%, cocoa 71%, lime flower 52% and camomile 47%. At the same polyphenol content, black tea inhibited more than cocoa and more than the camomile, vervain, lime flower and pennyroyal teas, and as much as peppermint tea. Adding milk to coffee and tea made little or no difference.
The arithmetic that makes it manageable. This is a luminal effect — the polyphenol and the iron have to be in the gut at the same time. That single fact explains the timing findings below:
- Timing matters more than abstinence. The iron-binding effect needs the tea and the iron to be in the gut together; in the 1999 study the drinks were taken with the meal. Tea drunk between meals, an hour or more either side of an iron-containing meal or an iron tablet, does not meet the meal's iron. A bedtime cup, which is the traditional use anyway, is nearly always well clear of dinner.
- Vitamin C counteracts it. Ascorbic acid overcomes polyphenol inhibition of non-haem iron in a dose-dependent way and is the standard countermeasure. See vitamin C and iron absorption.
- Strength and volume matter. One weak cup is not three strong ones. The effect is dose-related to polyphenol intake.
- It is not only vervain. If you are worried about iron, the black tea, coffee and cocoa in your day are almost certainly the larger contributors. Auditing only the herbal tea is missing the point.
Who the iron effect matters most for: anyone with diagnosed iron deficiency or iron-deficiency anaemia; anyone with heavy menstrual bleeding; pregnant people (for whom vervain already carries the pregnancy caution above); regular blood donors; vegetarians and vegans, whose iron is entirely non-haem; people with coeliac disease, inflammatory bowel disease or after bariatric surgery; and infants and young children. For everyone else with normal iron status and a mixed diet, a cup or two of any herbal tea is not a nutritional problem.
See iron-deficiency anaemia and iron for the wider picture. The same tannin logic applies to several other herbal infusions on this site — it is a class effect, not a vervain scandal.
Additive Sedation
Vervain is used as a sedative-leaning nervine and shows sedative effects in rodent screens. It is therefore reasonable to expect additive drowsiness when combined with other things that cause it, even though this has never been tested.
What the mouse study measured. The main rodent study (Khan, Khan and Ahmed, Frontiers in Pharmacology, 2016) gave mice a crude vervain extract. At 100–500 mg/kg the extract delayed the onset of seizures caused by the drug pentylenetetrazole, and the share of mice that died in that seizure test fell to 75% at 100 mg/kg and to 0% at 300–500 mg/kg. At 50–300 mg/kg it shortened the time to fall asleep and lengthened sleep after the sedative thiopental, and it had anxiety-reducing effects in maze and light-dark box tests. These were mice given extract doses far above what a cup of tea delivers; the sedation signal has not been measured in people.
Combinations where caution is warranted: prescription hypnotics such as the "z-drugs"; benzodiazepines; sedating antihistamines; opioid analgesics; some antidepressants and antipsychotics with sedative profiles; anti-epileptic drugs; alcohol; and other sedative herbs, which is the commonest real-world case because vervain is usually sold inside a multi-herb bedtime blend. Stacking three or four sedative herbs plus a prescription is a genuinely plausible way to be more impaired than you intended.
Note the anticonvulsant signal in the rodent work cuts both ways as a theoretical matter — interaction with anti-epileptic medication in either direction is conceivable and entirely unstudied. For anyone with epilepsy, vervain's effect alongside their medication is an unknown.
The risk here is not exotic, it is ordinary: extra drowsiness the next morning matters most for driving and other tasks that need alertness. With a prescription sedative, no dangerous interaction is documented — but nobody has looked.
Anticoagulants and Antiplatelets
Vervain appears on caution lists for use with warfarin, direct oral anticoagulants and antiplatelet drugs including aspirin and clopidogrel. It is worth being clear about where that caution comes from.
What exists: the listing itself, propagated through interaction compendia and herbal reference works. Plus a general and well-founded principle that polyphenol-rich botanicals can affect platelet function in laboratory settings.
What does not exist: any published interaction study of vervain with any anticoagulant; any case report of bleeding attributed to vervain that we can trace to a primary source; any identified coumarin or antiplatelet constituent characterised in V. officinalis; and any pharmacokinetic work that would let anyone predict an interaction.
So this is a theoretical concern of unclear provenance. That said, the asymmetry argument applies with force: the population most likely to be taking an anticoagulant is older, often on several medications, and the possible harm is a bleed. No interaction study exists, so whether vervain changes bleeding risk on these drugs is unknown.
Other Theoretical Interactions
- Drug absorption, generally. Tannins bind more than iron — they complex with alkaloids, some proteins and certain drug molecules in the gut. Keeping a tannin-containing infusion an hour or so away from oral medication avoids that overlap; this matters most for thyroid hormone, iron and bisphosphonates, all of which already carry timing instructions for the same reason.
- Cytochrome P450 and drug transporters. No data. Vervain has not been screened against the major cytochrome P450 enzymes or P-glycoprotein in any published work we can point to. That is a real gap for a plant taken alongside prescriptions, and it means the herb cannot be declared free of pharmacokinetic interactions — only unexamined.
- Blood pressure. Occasionally listed as mildly hypotensive. Not established, no human data, no reason for alarm, and no reason for confidence either.
- Blood glucose. Occasionally listed among glucose-lowering herbs on the basis of animal work. Not established in humans. Glucose monitoring is already part of insulin and sulfonylurea treatment.
- Gastrointestinal upset. The most commonly reported real-world complaint: nausea or stomach discomfort, particularly on an empty stomach or with strong preparations. Vervain is a bitter, and bitters affect gastric secretion by design. Not dangerous; taking it with or after food is the usual way round it, which trades off against the iron timing above.
Dose and Exposure: Tea Is Not a Capsule
Almost the entire benign safety record for vervain comes from one specific pattern of use: occasional to daily consumption of a weak water infusion of the dried herb. That is a small exposure. A teabag is around 1.5 to 2 grams, only the water-soluble fraction transfers into the cup, and nobody drinks it in quantity because it is bitter.
Concentrated products change the exposure without changing the evidence:
- Tinctures extract constituents water leaves behind, so the chemical profile differs from the traditional preparation, not just the strength.
- Extract capsules may concentrate the herb several-fold, are rarely standardised to any marker compound, and are dosed on no published dose-finding work whatsoever.
- Multi-herb formulas obscure how much vervain you are taking and are where sedative stacking happens.
We are not going to give you a maximum safe dose or a duration limit, and the reason is that we would be making it up. There is no repeat-dose toxicology, no human pharmacokinetics and no dose-finding study for vervain. Some herbs have a genuine mechanistic duration cap — uva ursi's hydroquinone, horsetail's thiamine destruction — where the number can be reasoned to. Vervain has no such mechanism identified, which means a confident limit here would be invented, and an invented limit is worse than an admitted gap because it sounds like knowledge. What can be said: the safety record covers the traditional exposure only, concentrated extracts sit outside it, and continuous use for months has never been studied.
Allergy, Skin and the Essential-Oil Confusion
Allergy to vervain is possible, as with any plant, and would present in the usual ways — rash, itching, swelling, or in rare cases something more severe. For people with multiple plant allergies, any new herb is a possible new allergen.
There is also a specific confusion worth heading off. Lemon verbena essential oil (Aloysia citrodora) carries recognised skin-sensitisation and phototoxicity concerns and is restricted in fragrance use for that reason. Common vervain contains little volatile oil — although the 2020 species review in Planta Medica does list essential oil among its constituents and notes its fragrance use in cosmetics — and those restrictions on lemon verbena oil have nothing to do with it. Meanwhile "verbena oil" on a fragrance label is frequently distilled from Litsea cubeba, a laurel-family tree, which is a third plant again. A reaction to something labelled verbena says nothing about vervain tea until it is known which of the three plants it was.
Identity and Quality Are Safety Issues
On most herb pages, species confusion is an accuracy problem. Here it is a safety problem, because the plants sharing the name have different cautions attached.
Consider what a jar labelled only "Vervain" might contain: V. officinalis, with the pregnancy caution; V. hastata, blue vervain, which its own American tradition describes as emetic in quantity; or a lemon verbena blend, with different concerns again. You cannot apply the right caution to an unidentified plant.
DNA-barcoding surveys of North American herbal products have found substitution and undeclared filler at rates high enough that a common name on a label is not identification. A 2019 global review of DNA tests on 5,957 herbal products sold in 37 countries found 27% adulterated — containing undeclared contaminant, substitute or filler species, or none of the species on the label — with 33% in North America and 29% in the USA. That finding is general to herbal commerce rather than specific to vervain — but a herb with four plants sharing its name is precisely where it does the most damage.
And note how the usual reassurance inverts. The standard defence when a herb is implicated in harm is "that was a substituted species, not the real plant" — the argument made for skullcap against germander, and for coltsfoot against a misidentified composite. That defence clears the plant and not the bottle. If the buyer cannot tell which plant is in the bottle, the hazard is worse, not better. The binomial, Verbena officinalis, printed on the package, and a supplier able to produce a certificate of analysis, are the label-level ways to know which plant it is.
Who the Research Raises Concerns For
- Anyone pregnant or trying to conceive. Two traditions list vervain as unsuitable in pregnancy, and a 2019 rat study found harm to foetuses at high doses.
- Anyone breastfeeding — not because harm is documented, but because nothing at all is.
- Children, for whom there are no dosing or safety data.
- Anyone with iron-deficiency anaemia who is not able to separate the tea from meals and iron tablets.
- Anyone on anticoagulant or antiplatelet therapy — no interaction study exists, and a bleed is the possible harm.
- Anyone on prescription sedatives, opioids or anti-epileptics — additive drowsiness is plausible and untested.
- Anyone taking concentrated extracts long-term — an exposure the safety record does not cover.
- Anyone using vervain in place of assessment for persistent insomnia, anxiety, unexplained fatigue or menstrual change. Those have causes worth finding.
- Anyone with a jar that does not name the species.
What Is Missing
The gaps, stated as findings:
- No human reproductive data for V. officinalis; one rat developmental-toxicity study (2019) found harm to foetuses, with incomplete bone formation at 2,000 and 3,000 mg/kg a day. The pregnancy caution rests on tradition and that animal study, not on human data.
- Genetic-safety testing only in the laboratory and in rats. A 2019 study found that a water extract of vervain leaves caused mutations in two strains of Salmonella bacteria (TA98 and TA100) in the Ames test, with and without liver-enzyme activation. In rats given 500, 1,000 or 2,000 mg/kg by mouth daily for three days, it caused no increase in bone-marrow micronuclei (a sign of chromosome damage).
- No repeat-dose or chronic toxicology, so no basis exists for a maximum dose or a duration limit.
- No human pharmacokinetics for any vervain constituent — absorption, half-life and active metabolite all unknown.
- No interaction studies with sedatives, anticoagulants, or the major drug-metabolising enzymes and transporters.
- No lactation data of any kind, in either direction, despite a galactagogue tradition.
- One measured iron-absorption figure for vervain — 59% less iron absorbed from a bread meal, from a single 1999 human study.
- No adverse-event surveillance. The empty case-report literature reflects nobody looking.
- No published survey of what is sold as vervain, so the real substitution rate for this name is unknown.
Notice the shape of this list against the benefits pages: for vervain, the best-established facts about the plant are not benefits at all. They are a mechanism in mice, a measured iron effect shared with other herbal and black teas, and a pregnancy caution reached by two traditions independently and backed by one rat study. That is worth saying plainly, because the marketing never does.
Key Research Papers
Where a paper's record has been verified, the citation closes with its PubMed PMID link. The others describe a body of literature and link a PubMed topic search.
- Hurrell RF, Reddy M, Cook JD. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. British Journal of Nutrition. 1999;81(4):289-95. The controlled human absorption study behind the tannin caution; vervain tea cut iron absorption from a bread meal by 59%. PubMed PMID: 10999016
- The effect of tea on iron absorption — Gut, 1975. The earlier work establishing that a tannin-rich beverage taken with a meal substantially reduces iron uptake. PubMed search
- Ascorbic acid and the absorption of non-haem iron — the dose-dependent countermeasure to polyphenol inhibition, established in human absorption studies. PubMed search
- Kubica P, Szopa A, Dominiak J, Luczkiewicz M, Ekiert H. Verbena officinalis (Common Vervain) – A Review on the Investigations of This Medicinally Important Plant Species. Planta Medica. 2020;86(17):1241-1257. The best species-specific review, and the place to confirm how little safety work exists. PubMed PMID: 32937665
- Khan AW, Khan AU, Ahmed T. Anticonvulsant, Anxiolytic, and Sedative Activities of Verbena officinalis. Frontiers in Pharmacology. 2016;7:499. The mouse study behind the additive-sedation caution. PubMed PMID: 28066246
- Fateh AH, Mohamed Z, Chik Z, Alsalahi A, Md Zin SR, Alshawsh MA. Prenatal developmental toxicity evaluation of Verbena officinalis during gestation period in female Sprague-Dawley rats. Chemico-Biological Interactions. 2019;304:28-42. The rat study (OECD guideline 414) that found harm to foetuses at 2,000 and 3,000 mg/kg a day. PubMed PMID: 30807743
- Fateh AH, Mohamed Z, Chik Z, Alsalahi A, Md Zain SR, Alshawsh MA. Mutagenicity and genotoxicity effects of Verbena officinalis leaves extract in Sprague-Dawley Rats. Journal of Ethnopharmacology. 2019;235:88-99. Ames-test mutations in two bacterial strains; no bone-marrow micronucleus increase in rats. PubMed PMID: 30738113
- Herbal medicinal products during pregnancy: are they safe? — BJOG, 2002. The framing paper for why absent data in pregnancy is not reassurance. PubMed search
- Herbal medicine use in pregnancy: prevalence and patterns — the survey literature showing how common unreported herbal use in pregnancy is, which is why this caution needs stating loudly. PubMed search
- Ichim MC. The DNA-Based Authentication of Commercial Herbal Products Reveals Their Globally Widespread Adulteration. Frontiers in Pharmacology. 2019;10:1227. 5,957 products from 37 countries, 27% adulterated; why an unverified label is not an identification. PubMed PMID: 31708772
- Herb–drug interactions with warfarin and antiplatelet agents — the review literature that generates lists like the one vervain appears on, and which is worth reading to see how thin some entries are. PubMed search
- Under-reporting of complementary medicine use to clinicians — the surveillance gap in numbers, and the reason "no case reports" means so little. PubMed search
- Ma bian cao (Verbena officinalis) in traditional Chinese use — the same species under its Chinese name, including the traditional pregnancy prohibition that independently corroborates the European caution. PubMed search
External Resources
- LactMed (Drugs and Lactation Database) — the standard reference for what is and is not known about a substance in breastfeeding.
- National Center for Complementary and Integrative Health (NCCIH) — Herbs at a Glance
- European Medicines Agency herbal medicinal products page
Connections
- All Herbs
- Vervain — main research page
- Vervain Benefits — deep-dive hub
- Which Vervain? Untangling the Names
- Vervain for Anxiety, Sleep and Nervous Tension
- Vervain Chemistry and Research
- Motherwort: Cardiac Interactions, Pregnancy and Safety
- Motherwort: Menstrual and Postpartum Tradition
- Raspberry Leaf, Pregnancy and Labour
- Horehound: Blood Pressure, Pregnancy and Safety
- Germander Adulteration and Liver Safety
- Iron-Deficiency Anaemia
- Iron and Anaemia
- Iron
- Vitamin C, Iron Absorption and Anaemia
- Nettle: Nutrition, Iron and Herb as Food
- Kava for Anxiety — and its liver warning
- Insomnia
- Anxiety